Liberty Latin America Ltd. (LILAB) Scorecard
- 2026-Q2: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2026-Q1: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2025-Q4: Total return Win; Revenue growth Lose; EPS growth Lose.
- 2025-Q3: Total return Win; Revenue growth Lose; EPS growth Win.
23/120
All 120 Win/Lose results shown below
Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
Trailing 1 year (4 quarters): 3 wins, 9 lossesLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q20/3 |
LoseLILAB / S&P -29.20% / 15.20% |
LoseLILAB / S&P 1.31% / 15.00% |
LoseLILAB / S&P -91.95% / 50.40% |
| 2026-Q10/3 |
LoseLILAB / S&P -4.66% / -4.33% |
LoseLILAB / S&P 0.24% / 11.30% |
LoseLILAB / S&P -40.81% / 27.70% |
| 2025-Q41/3 |
WinLILAB / S&P 19.33% / 2.65% |
LoseLILAB / S&P -0.10% / 9.00% |
LoseLILAB / S&P -12.57% / 13.40% |
| 2025-Q32/3 |
WinLILAB / S&P 62.16% / 8.12% |
LoseLILAB / S&P -1.06% / 4.61% |
WinLILAB / S&P 31.40% / 13.45% |
| 2025-Q21/3 |
LoseLILAB / S&P 0.00% / 10.94% |
LoseLILAB / S&P -2.38% / 4.83% |
WinLILAB / S&P 1350.00% / 10.63% |
| 2025-Q12/3 |
WinLILAB / S&P 0.00% / -4.27% |
LoseLILAB / S&P -1.73% / 4.98% |
WinLILAB / S&P 10375.00% / 10.57% |
| 2024-Q41/3 |
LoseLILAB / S&P -35.76% / 2.41% |
LoseLILAB / S&P -1.43% / 5.25% |
WinLILAB / S&P 929.41% / 6.15% |
| 2024-Q30/3 |
LoseLILAB / S&P -9.05% / 5.89% |
LoseLILAB / S&P -0.81% / 5.89% |
LoseLILAB / S&P -485.53% / 6.11% |
| 2024-Q20/3 |
LoseLILAB / S&P -5.00% / 4.28% |
LoseLILAB / S&P -2.06% / 5.38% |
LoseLILAB / S&P -151.85% / 5.12% |
| 2024-Q11/3 |
WinLILAB / S&P 25.00% / 10.56% |
LoseLILAB / S&P -4.02% / 5.71% |
LoseLILAB / S&P -97.26% / 5.59% |
| 2023-Q40/3 |
LoseLILAB / S&P -11.01% / 11.69% |
LoseLILAB / S&P -6.26% / 6.81% |
LoseLILAB / S&P -58.02% / 7.78% |
| 2023-Q30/3 |
LoseLILAB / S&P -10.10% / -3.27% |
LoseLILAB / S&P -8.59% / 7.52% |
LoseLILAB / S&P -118.77% / -5.03% |
| 2023-Q21/3 |
WinLILAB / S&P 24.84% / 8.74% |
LoseLILAB / S&P -6.20% / 9.50% |
LoseLILAB / S&P -119.90% / -8.57% |
| 2023-Q10/3 |
LoseLILAB / S&P -15.42% / 7.50% |
LoseLILAB / S&P -3.40% / 10.77% |
LoseLILAB / S&P -23.56% / -15.69% |
| 2022-Q41/3 |
WinLILAB / S&P 18.38% / 7.56% |
LoseLILAB / S&P 0.01% / 11.88% |
LoseLILAB / S&P -56.91% / -17.99% |
| 2022-Q31/3 |
WinLILAB / S&P 6.67% / -4.88% |
LoseLILAB / S&P 6.03% / 13.47% |
LoseLILAB / S&P -587.95% / -1.41% |
| 2022-Q20/3 |
LoseLILAB / S&P -16.67% / -16.10% |
LoseLILAB / S&P 13.01% / 13.71% |
LoseLILAB / S&P -8240.00% / 11.04% |
| 2022-Q11/3 |
LoseLILAB / S&P -16.67% / -4.60% |
WinLILAB / S&P 21.07% / 15.97% |
LoseLILAB / S&P -9.91% / 42.23% |
| 2021-Q41/3 |
LoseLILAB / S&P -27.56% / 11.03% |
WinLILAB / S&P 27.22% / 15.00% |
LoseLILAB / S&P -45.98% / 96.40% |
| 2021-Q31/3 |
LoseLILAB / S&P 0.00% / 0.58% |
WinLILAB / S&P 27.67% / 10.77% |
LoseLILAB / S&P LILAB unavailable / 69.42% |
| 2021-Q21/3 |
LoseLILAB / S&P 0.00% / 8.55% |
WinLILAB / S&P 16.65% / 6.58% |
LoseLILAB / S&P LILAB unavailable / 51.81% |
| 2021-Q11/3 |
LoseLILAB / S&P 0.00% / 6.17% |
WinLILAB / S&P 4.18% / -1.06% |
LoseLILAB / S&P LILAB unavailable / 7.39% |
| 2020-Q41/3 |
LoseLILAB / S&P 0.00% / 12.15% |
WinLILAB / S&P -2.19% / -3.72% |
LoseLILAB / S&P LILAB unavailable / -33.42% |
| 2020-Q30/3 |
LoseLILAB / S&P 0.00% / 8.93% |
LoseLILAB / S&P -5.18% / -2.04% |
LoseLILAB / S&P LILAB unavailable / -27.10% |
| 2020-Q20/3 |
LoseLILAB / S&P 13.33% / 20.54% |
LoseLILAB / S&P -2.05% / -0.46% |
LoseLILAB / S&P LILAB unavailable / -27.11% |
| 2020-Q11/3 |
WinLILAB / S&P -16.67% / -19.60% |
LoseLILAB / S&P 3.12% / 3.47% |
LoseLILAB / S&P LILAB unavailable / -14.75% |
| 2019-Q40/3 |
LoseLILAB / S&P 0.00% / 9.07% |
LoseLILAB / S&P 4.35% / 5.36% |
LoseLILAB / S&P LILAB unavailable / 2.99% |
| 2019-Q31/3 |
LoseLILAB / S&P 0.00% / 1.70% |
WinLILAB / S&P 6.48% / 5.02% |
LoseLILAB / S&P LILAB unavailable / 0.21% |
| 2019-Q20/3 |
LoseLILAB / S&P 0.00% / 4.30% |
LoseLILAB / S&P 5.82% / 6.64% |
LoseLILAB / S&P LILAB unavailable / 8.65% |
| 2019-Q10/3 |
LoseLILAB / S&P -5.26% / 13.65% |
LoseLILAB / S&P 4.17% / 8.12% |
LoseLILAB / S&P LILAB unavailable / 14.29% |
| 2018-Q41/3 |
WinLILAB / S&P 0.00% / -13.52% |
LoseLILAB / S&P LILAB unavailable / 9.05% |
LoseLILAB / S&P LILAB unavailable / 18.23% |
| 2018-Q30/3 |
LoseLILAB / S&P -3.80% / 7.71% |
LoseLILAB / S&P LILAB unavailable / 10.21% |
LoseLILAB / S&P LILAB unavailable / 19.06% |
| 2018-Q20/3 |
LoseLILAB / S&P -4.68% / 3.43% |
LoseLILAB / S&P LILAB unavailable / 9.03% |
LoseLILAB / S&P LILAB unavailable / 14.46% |
| 2018-Q11/3 |
WinLILAB / S&P 0.00% / -0.76% |
LoseLILAB / S&P LILAB unavailable / 7.68% |
LoseLILAB / S&P LILAB unavailable / 12.46% |
| 2017-Q40/3 |
LoseLILAB / S&P -11.00% / 6.64% |
LoseLILAB / S&P LILAB unavailable / 7.03% |
LoseLILAB / S&P LILAB unavailable / 13.82% |
| 2017-Q31/3 |
WinLILAB / S&P 9.19% / 4.48% |
LoseLILAB / S&P LILAB unavailable / 5.68% |
LoseLILAB / S&P LILAB unavailable / 17.57% |
| 2017-Q20/3 |
LoseLILAB / S&P -14.14% / 3.09% |
LoseLILAB / S&P LILAB unavailable / 4.83% |
LoseLILAB / S&P LILAB unavailable / 17.74% |
| 2017-Q11/3 |
WinLILAB / S&P 21.24% / 6.07% |
LoseLILAB / S&P LILAB unavailable / 3.67% |
LoseLILAB / S&P LILAB unavailable / 13.32% |
| 2016-Q40/3 |
LoseLILAB / S&P -28.89% / 3.82% |
LoseLILAB / S&P LILAB unavailable / 2.09% |
LoseLILAB / S&P LILAB unavailable / 7.05% |
| 2016-Q30/3 |
LoseLILAB / S&P -19.15% / 3.85% |
LoseLILAB / S&P LILAB unavailable / 0.20% |
LoseLILAB / S&P LILAB unavailable / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-28
| Metric | LILAB total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -17.22% | 20.78% |
| Annualized return | -17.22% | 20.78% |
5Y · 2021-09-01 to 2026-08-28
| Metric | LILAB total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -50.03% | 83.14% |
| Annualized return | -12.96% | 12.86% |
10Y · 2016-09-01 to 2026-08-28
| Metric | LILAB total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -69.82% | 319.30% |
| Annualized return | -11.29% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-04.